TLR2 and inflammatory bowel disease: This inhibitory action is impaired in IBD individuals as revealed by assessment of butyrate effect on cytokines production by peripheral blood mononuclear cells (PBMC) isolated from IBD and healthy subjects in response to TLR-2 activation (Kovarik et al., 2011).